| ¿µ¹® | protein | ÇÑ±Û | ´Ü¹éÁú |
|---|---|---|---|
| ¼³¸í | ź¼Ò, ¼ö¼Ò, »ê¼Ò, Áú¼Ò, ȲÀ» ÇÔÀ¯Çϰí ÀÖ´Â À¯±âÈÇÕ¹°·Î, ¸ðµç ¼¼Æ÷ÀÇ ¿øÇüÁúÀ» ÀÌ·ç°í ÀÖ´Â ±âº» ±¸¼º¹°ÁúÀÌ´Ù. ´Ü¹éÁúÀº ±× ´ÜÀ§ÀÎ ¾Æ¹Ì³ë»êµéÀÌ ÆéƼµå°áÇÕ¿¡ ÀÇÇØ °áÇյǾî ÀÖÀ¸¸ç, º¸Åë 20°³ÀÇ ¾Æ¹Ì³ë»êµéÀÌ ´Ù¸¥ ¼ø¼¿Í Á¶¼ºÀ» °¡Áö°í ¹è¿µÇ¾î, µ¶Æ¯ÇÑ ÇϳªÀÇ ´Ü¹éÁúÀ» Çü¼ºÇÏ°Ô µÈ´Ù. |
||
| ¿µ¹® | malnutrition | ÇÑ±Û | ¿µ¾ç½ÇÁ¶ |
|---|---|---|---|
| ¼³¸í | Á¥¸ÔÀÌ ¶Ç´Â À¯¾ÆÀÇ Ã¼ÁßÀÌ Ç¥ÁØÀÇ 20% °¨¼ÒÀÌÇÏ »óŸ¦ ¸»ÇÑ´Ù. Áõ»óÀ¸·Î¼´Â º¸±â¿¡ ¸»¶úÀ¸¸ç °æ°ú¸¦ °üÂûÇØµµ üÁß°î¼±ÀÌ ¼öÆòÀ̰ųª ¶Ç´Â ¼¼È÷ ÇϰÇÑ´Ù. ±âºÐÀÌ ³ª»Ú¸ç Àß ¿ï°í Àáµµ Àß ÀÚÁö ¸øÇϰí ü¿ÂÀÇ µ¿¿ä°¡ ½±°Ô »ý±ä´Ù. üÁßÀÌ Ç¥ÁØÀÇ 60% °¨¼Ò ÀÌÇÏÀÎ °æ¿ì¿¡´Â ¼Ò¸ðÁõ(marasmus)À̶ó Çϸç, ¿µ¾ç½ÇÁ¶ÀÇ Áõ»óÀÌ ¾ø°í üÁß°ú ½ÅÀåÀÇ µ¿ÀÏÇÑ ºñÀ²·Î ÇöÀúÇÏ°Ô Ç¥ÁØ ÀÌÇÏÀÎ °æ¿ì¿¡´Â ¹ßÀ°ºÎÁ·À̶ó ÇÑ´Ù. ¿øÀÎÀ¸·Î´Â À߸øµÈ ¿µ¾çÀÇ ¼·Ãë, ¸¸¼ºº´À̳ª üÁú¿¡ ÀÇÇÑ À½½Ä¹°ÀÇ ¼ÒÈ-Èí¼öºÒ·®-°¨¿° Áõ µîÀÇ ¿øÀκ´ÀÌ ÀÖ´Â °æ¿ì, Á¤¼ºÒ¾ÈÁ¤ µîÀÌ ÀÖ´Ù. |
||
| PEM | Protein-Energy Malnutrition = PCM; Protein Calorie Malnutrition |
|---|---|
| PCM | patient care manager or management; patient classification system; primary cutaneous melanoma; proce... |
| PCM | Protein Calorie Malnutrition = PEM |
| EPM | electron probe microanalysis; electrophoretic mobility; energy-protein malnutrition |
| PEM | pediatric emergency medicine; peritoneal exudate macrophage; polymorphic epithelial mucin; prescript... |
| PEM | PROTEIN-ENERGY-malnutrition |
|---|---|
| MRDM | Malnutrition-Related Diabetes Mellitus |
| PCM | Proteic Caloric Malnutrition |
| G protein | 5'-triphosphate-binding protein |
| G-protein | Guanine nucleotide-binding protein |
| protein malnutrition | Children are particularly prone to develop protein malnutrition. To grow, children have to consume enough nitrogen-containing food (protein) to maintain a positive nitrogen balance whereas adults need only be in nitrogen equilibrium. (12 Dec 1998) |
|---|
| protein-calorie malnutrition | Severe deficiency of protein + inadequate caloric intake = kwashiorkor. (12 Dec 1998) |
|---|---|
| protein-energy malnutrition | The lack of sufficient energy or protein to meet the body's metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses. (12 Dec 1998) |
| malignant malnutrition | A nutritional deficiency illness in children who are not getting enough protein, this results in anaemia, poor growth, weakness, and oedema (which isparticularly characterised by a pronounced pot belly). Infamine-stricken regions, children typically develop kwashiorkor rightafter they are weaned. (09 Oct 1997) |
| malnutrition | Faulty or inadequate nutrition. Under nourishment. (27 Sep 1997) |
| acetoacetyl-acyl carrier protein synthase | <enzyme> E coli enzyme, that catalyses condensation of malonyl-acyl carrier protein plus acetyl-acyl carrier protein; not inhibited by cerulenin Registry number: EC 2.3.1.- Synonym: acetoacetyl-acp synthase (26 Jun 1999) |
| acid soluble spore protein | <molecular biology> A DNA binding protein in the spores of some bacteria, thought to stabilise the DNA in an A configuration, so protecting it from cleavage by enzymes or UV light. (18 Nov 1997) |
| acute-phase protein | <haematology> These plasma proteins (in addition to fibrinogen) increase 25% or more in response to inflammation and injury are under direct control of interleukin-6 (IL-6) (hepatocyte-stimulating factor). Other proteins which increase are ceruloplasmin, C3 and C4 which increase 50% or more; alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin and fibrinogen (the major determinant of viscosity 1 ) which increase two- to fourfold; C-reactive protein (CRP) and serum amyloid A which increase several hundred-fold. Despite long-held clinical opinion to the contrary, available data indicate that neither ESR nor measurement of specific acute-phase reactants are useful in excluding underlying infection or inflammation regardless of the pretest probability. These proteins are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. They can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumour markers. See also: amyloid, c-reactive protein, erythrocyte sedimentation rate, viscosity. (25 Jun 1999) |
| acyl-(acyl-carrier-protein)-phospholipid acyltransferase | <enzyme> Catalyses the formation of phosphatidylethanolamine from acyl-acyl carrier protein and 2-acyl-sn-glycero-3-phosphoethanolamine Registry number: EC 2.3.1.40 Synonym: 2-acyl-gpe acyltransferase, 2-acylglycerophosphoethanolamine acyltransferase (26 Jun 1999) |
| acyl-(acyl-carrier-protein)-UDP-N-acetylglucosamine acyltransferase | <enzyme> E coli enzyme involved in lipid a biosynthesis; uses beta-hydroxymyristoyl-acyl carrier protein to form udp-3-monoacyl-n-acetylglucosamine; amino acid sequence given in second source Registry number: EC 2.3.1.129 Synonym: udp-aguatransferase, lpxa protein, udp-n-acetylglucosamine-3-acyltransferase, udp-n-acetylglucosamine 3-o-acyltransferase, udp-3-o-(r-3-hydroxymyristoyl)glucosamine-n-acyltransferase, lpxd protein, fira gene product, fira protein (26 Jun 1999) |
| acyl carrier protein | <protein> A small (77 peptides long) protein which binds six other enzymes involved in fatty acid synthesis. It was first isolated in E. Coli bacteria. (09 Oct 1997) |
| acyl carrier protein acylase | <enzyme> From E coli Registry number: EC 2.3.1.- Synonym: acp acylase (26 Jun 1999) |
| acyl protein synthetase | <enzyme> Component of the fatty acid reductase complex of luminescent bacteria Registry number: EC 2.3.1.- Synonym: luxe gene product, fatty acyl-protein synthetase (26 Jun 1999) |
| AKT1 protein kinase | <enzyme> Human homolog of v-akt oncogene product Registry number: EC 2.7.10.- Synonym: akt1 protein, human (26 Jun 1999) |
| AMP-activated protein kinase kinase | <enzyme> An endogenous kinase kinase; reactivates the inactive form of AMP-activated protein kinase (AMP-pk); phosphorylates the 63-kD subunit of AMP-pk Registry number: EC 2.7.1.- Synonym: AMP-pk reactivator, hmg CoA reductase kinase kinase (26 Jun 1999) |
| amyloid beta-protein | A 4 kD protein, 39-43 amino acids long, expressed by a gene located on chromosome 21. It is the major protein subunit of the vascular and plaque amyloid filaments in individuals with alzheimer's disease and in aged individuals with trisomy 21 (down syndrome). The protein is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|